To determine the incidence of oesophageal carcinoma in patients with achalasia and to establish the efficacy of endoscopic surveillance, 195 consecutive patients with achalasia (90 men and 105 women, mean age 52 years), who were treated by pneumatic dilatation in our institution between 1973 and 1988 were prospectively studied. None of the patients had undergone cardiomyotomy. Follow up totalled 874 person years after pneumatic dilatation. In this period three patients developed an oesophageal squamous cell carcinoma. The mean age at diagnosis of the oesophageal carcinoma was 68 years (37, 77, and 89 years). The mean period between the onset of dysphagia and the diagnosis of the tumour was 17 years (19, 28, and 5 years); the mean interval between the diagnosis of achalasia and carcinoma was 5*7 years (5, 8, and 4 years). The incidence of oesophageal squamous cell carcinoma in this series (3.4/1000 patients per year) is significantly higher than the statistically expected incidence (0-104/1000 patients per year) using age and sex specific incidence data from the population of the Netherlands (Poisson statistics: p<O0OOl). 
, and 5 years); the mean interval between the diagnosis of achalasia and carcinoma was 5*7 years (5, 8 , and 4 years). The incidence of oesophageal squamous cell carcinoma in this series (3.4/1000 patients per year) is significantly higher than the statistically expected incidence (0-104/1000 patients per year) using age and sex specific incidence data from the population of the Netherlands (Poisson statistics: p<O0OOl). patients per year, which means a 33 fold increased risk of developing carcinoma of the oesophagus in comparison with a control population. Achalasia, therefore, certainly seems a high *risk factor for the development of oesophageal squamous cell carcinoma. The mean age of the patients with oesophageal squamous cell carcinoma in this series was 68 years (range 37-89 years). This is at variance with the published reports; the reported mean age at which oesophageal squamous cell carcinoma is found in patients with achalasia is 48-51 years, which is lower than the mean age at which oesophageal carcinoma occurs in the normal population (62-67 years).24814 However, as the duration of dysphagia seems more important in developing oesophageal squamous cell carcinoma than the age of the patient,8 12-14 our results may merely reflect differences in patient populations. This is corroborated by the fact that we found a mean interval of 17 years from the onset of dysphagia to the diagnosis of oesophageal squamous cell carcinoma, which equals the reported mean interval of 17-20 years. 8 12-14 In two of our patients with an oesophageal squamous cell carcinoma, a small tumour was detected in the middle third of the oesophagus, whereas in the third patient the tumour extended to both the middle and distal parts. This is in accordance with the fact that in patients with achalasia oesophageal squamous cell carcinoma occurs most frequently in the middle third of the oesophagus.3 4 7`112 If chronic stagnation of food and saliva plays a major role in the cause of carcinoma, as suggested by some authors,78'4 adequate relief by pneumatic dilatation would be expected to prevent the development of carcinoma. This could explain the development of oesophageal squamous cell carcinoma in patients 1 and 2, in whom some material was still retained in the oesophagus after dilatation despite satisfactory symptomatic relief. Consequently, subjective criteria may not reflect the adequacy of dilatation therapy.
By the time symptoms of oesophageal carcinoma are evident over and above the dysphagia of achalasia, the tumour is usually advanced, resulting in a poor prognosis for the patient: 80% of patients with achalasia and carcinoma of the oesophagus have been found unsuitable for operation. 15 Early detection of oesophageal squamous cell carcinoma improves the survival rate after oesophageal resection: the three-year survival after resection for stage I or II disease is 8% v 25% for stage III carcinoma.202' It is, therefore, important to determine a safe period of time after achalasia has been diagnosed. In our study the interval between the diagnosis of achalasia and carcinoma was mean (range) 5 7 (4-8) years, suggesting a relatively long safe interval. Our results contrast, however, with those of Norton et al, who reported a range of 1 5-61 years between the diagnosis of achalasia and carcinoma.'3 Unfortunately, no data on the duration of dysphagia were mentioned in this retrospective study by Norton. Therefore to detect oesophageal squamous cell carcinoma at an early stage it is still difficult to state a safe period of time after which screening should be started.
There is indirect evidence supporting endoscopic surveillance. Oesophageal squamous cell carcinoma evolves through a series of progressively dysplastic changes.2026 According to studies of cell growth kinetics and data from mass screening programmes, progression from carcinoma in situ to invasive oesophageal squamous cell carcinoma may take three to four years.27 28 This may support routine endoscopy as a means of detecting carcinomas at an early, potentially curable stage. In patient 2 in this study routine endoscopy detected a superficial asymptomatic oesophageal squamous cell carcinoma. In case 1, although this patient was not asymptomatic, endoscopy revealed an early oesophageal squamous cell carcinoma. To date both patients are without signs of local recurrence or metastasis three and six years respectively after oesophageal resection.
Based on the above data, an endoscopic screening interval of two to three years seems safe.2728 Although this interval proved to be valid in our study, we cannot recommend a safe screening interval from data obtained in only three patients. Therefore, the value of endoscopic screening continues to be disputable, because its efficacy in reducing morbidity and mortality from oesophageal squamous cell carcinoma will require a larger number of patients with achalasia and a longer follow up than in our study to confirm such an effect.29
In conclusion, achalasia seems a high risk factor for oesophageal squamous cell carcinoma considering the 33 fold increased risk of developing this carcinoma in patients with achalasia. Endoscopic screening has the potential for detecting oesophageal squamous cell carcinoma in an early, non-symptomatic stage. To obtain some cost benefit, only patients fit for oesophageal resection should be screened. However, a large scale study is needed to demonstrate the benefit of endoscopic screening on the prognosis of patients with achalasia who develop oesophageal carcinoma.
